TG Therapeutics, Inc. (NASDAQ: TGTX) shares climbed in Tuesday’s extended trading after the company released its preliminary fourth quarter revenue estimates and provided an optimistic outlook for ...
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United ...
A TG Therapeutics multiple sclerosis drug that’s new to the U.S. market will be commercialized in Europe and other regions under a partnership that pays the biotech $140 million up front. According to ...
TG Therapeutics is winding down its oncology program after removing the FDA-approved cancer med Ukoniq from the market in two indications that were granted accelerated approval in addition to ...
Zacks Investment Research on MSN
TG Therapeutics stock rises 7% on strong Q4 & 2025 preliminary results
TG Therapeutics’ TGTX shares rose nearly 7% in after-hours trading, following the release of preliminary fourth-quarter and full-year 2025 results on Jan. 13, which beat expectations. TGTX issued ...
Excellent image quality for small camera. Support for RAW images. Bright rear LCD. Wide range of accessories to build out a full underwater kit. Durable design that's nearly everything-proof. Menu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results